RoseRx Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
8
RoseRx General Information
Description
Developer of a digital activation and engagement platform designed to help people navigate their health at scale. The company's platform offers personalized healthcare journeys that improve engagement and provide value for patients, healthcare personnel, and life sciences companies by ethically empowering patients to take action and accelerate their journey to earlier diagnosis and access life-changing treatment, enabling customers to make the transition from awareness to action and get the treatment.
Contact Information
Website
roserx.aiCorporate Office
- 300 Barangaroo Avenue
- Sydney, New South Wales 2000
- Australia
Corporate Office
- 300 Barangaroo Avenue
- Sydney, New South Wales 2000
- Australia
RoseRx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 5. Early Stage VC | Completed | Generating Revenue | ||||
| 4. Early Stage VC (Series A) | 01-Sep-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 07-Apr-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 04-Nov-2020 | $2.17M | $2.83M | Completed | Generating Revenue | |
| 1. Angel (individual) | 25-Jan-2020 | $657K | $657K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
RoseRx Comparisons
Industry
Financing
Details
RoseRx Competitors (2)
One of RoseRx’s 2 competitors is IQVIA Holdings, a Formerly PE-Backed company based in Durham, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IQVIA Holdings | Formerly PE-Backed | Durham, NC | ||||
| Veeva Systems | Formerly VC-backed | Pleasanton, CA |
RoseRx Signals
RoseRx Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| PharmStars | Accelerator/Incubator | |||
| Clearsign Capital | Family Office | Minority | ||
| Polipo Ventures | Venture Capital | Minority | ||
| Artesian | Venture Capital | Minority | ||
| Breyer Capital | Venture Capital | Minority |
RoseRx FAQs
-
When was RoseRx founded?
RoseRx was founded in 2019.
-
Where is RoseRx headquartered?
RoseRx is headquartered in Sydney, Australia.
-
What is the size of RoseRx?
RoseRx has 19 total employees.
-
What industry is RoseRx in?
RoseRx’s primary industry is Practice Management (Healthcare).
-
Is RoseRx a private or public company?
RoseRx is a Private company.
-
What is RoseRx’s current revenue?
The current revenue for RoseRx is .
-
How much funding has RoseRx raised over time?
RoseRx has raised $11.2M.
-
Who are RoseRx’s investors?
PharmStars, Clearsign Capital, Polipo Ventures, Artesian, and Breyer Capital are 5 of 8 investors who have invested in RoseRx.
-
Who are RoseRx’s competitors?
IQVIA Holdings and Veeva Systems are competitors of RoseRx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process